Insider Transactions in Q2 2021 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,859
-3.97%
|
$56,577
$3.51 P/Share
|
|
Jun 30
2021
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
3,551
-3.26%
|
$10,653
$3.51 P/Share
|
|
Jun 30
2021
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,083
-3.12%
|
$9,249
$3.51 P/Share
|
|
Jun 30
2021
|
Matthew T. Wiley Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,151
-4.5%
|
$15,453
$3.51 P/Share
|
|
Jun 30
2021
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
700
-2.99%
|
$2,100
$3.51 P/Share
|
|
May 28
2021
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
941
+0.2%
|
$2,823
$3.36 P/Share
|
|
May 28
2021
|
Andrew Saik Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,017
+2.53%
|
$9,051
$3.36 P/Share
|
|
May 26
2021
|
Patrick G Lepore Director |
BUY
Open market or private purchase
|
Direct |
12,500
+25.0%
|
$37,500
$3.6 P/Share
|
|
May 06
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-14.76%
|
$3,000,000
$3.67 P/Share
|